Letter: Editorial Comment on “Medium-Term Outcomes after Primary Whole-Gland High-Intensity Focused Ultrasound Ablation for the Treatment of Prostate Cancer: A Single-Center Experience”
Restricted accessResearch articleFirst published online March, 2026
Letter: Editorial Comment on “Medium-Term Outcomes after Primary Whole-Gland High-Intensity Focused Ultrasound Ablation for the Treatment of Prostate Cancer: A Single-Center Experience”
BrazãoÉS, OliveiraRAR, ZanottiRR, et al.Medium-Term outcomes after primary whole-gland high-intensity focused ultrasound ablation for the treatment of prostate cancer: A single-center experience. J Endourol, 2025; 39(5):500–508; doi: 10.1089/end.2024.0539
2.
AlbertiA, NicolettiR, CastellaniD, et al.Patient-reported outcome measures and experience measures after active surveillance versus radiation therapy versus radical prostatectomy for prostate cancer: A systematic review of prospective comparative studies. Eur Urol Oncol, 2024; 7(6):1255–1266; doi: 10.1016/j.euo.2024.05.008
3.
DeivasigamaniS, KotamartiS, RastinehadAR, et al.; Focal Therapy Society. Primary whole-gland ablation for the treatment of clinically localized prostate cancer: A focal therapy society best practice statement. Eur Urol, 2023; 84(6):547–560; doi: 10.1016/j.eururo.2023.06.013
4.
NicolettiR, AlbertiA, CastellaniD, et al.Functional outcomes and safety of focal therapy for prostate cancer: A systematic review on results and Patient-Reported Outcome Measures (PROMs). Prostate Cancer Prostatic Dis, 2024; 27(4):614–622; doi: 10.1038/s41391-023-00698-8
5.
DellabellaM, BranchiA, Di RosaM, et al.Oncological and functional outcome after partial prostate HIFU ablation with Focal-One®: A prospective single-center study. Prostate Cancer Prostatic Dis, 2021; 24(4):1189–1197; doi: 10.1038/s41391-021-00390-9
6.
NicolettiR, AlbertiA, CastellaniD, et al.Oncological results and cancer control definition in focal therapy for Prostate Cancer: A systematic review. Prostate Cancer Prostatic Dis, 2024; 27(4):623–634; doi: 10.1038/s41391-023-00699-7
